Table 1.
Characteristics of patients.
| Variable | CE (n = 232) ESPEN criteria |
AE (n = 164) ESPEN criteria |
||||
|---|---|---|---|---|---|---|
| Not malnourished (n = 165) | Malnourished (n = 67) | p-value | Not malnourished (n = 112) | Malnourished (n = 52) | p-value | |
| Clinical parameters | ||||||
| Age | 46.91 ± 13.65 | 37.73 ± 16.78 | 0.001* | 41.91 ± 14.45 | 37.35 ± 14.87 | 0.064 |
| Gender | ||||||
| Male | 69 | 30 | 0.680 | 47 | 23 | 0.785 |
| Female | 96 | 37 | 65 | 29 | ||
| Height | 1.67 ± 0.15 | 1.65 ± 0.13 | 0.341 | 1.63 ± 0.11 | 1.62 ± 0.14 | 0.621 |
| Weight | 66.64 ± 10.91 | 49.09 ± 11.34 | <0.001* | 61.72 ± 11.27 | 48.59 ± 8.92 | <0.001* |
| BMI (kg/m2) | 22.26 ± 2.74 | 17.74 ± 1.52 | <0.001* | 23.13 ± 3.09 | 18.14 ± 1.47 | <0.001* |
| ALB (U/L) | 36.22 ± 5.01 | 32.41 ± 4.67 | 0.001* | 36.67 ± 4.51 | 32.70 ± 5.10 | <0.001* |
| HGB (g/L) | 143.56 ± 24.38 | 136.74 ± 25.96 | 0.058 | 136.06 ± 24.52 | 120.02 ± 25.29 | <0.001* |
| LYMPH (109/L) | 1.71 ± 0.60 | 1.70 ± 0.75 | 0.901 | 1.66 ± 0.68 | 1.73 ± 0.73 | 0.574 |
| Lesion size | 7.62 ± 3.24 | 11.81 ± 5.85 | <0.001* | 10.01 ± 4.51 | 13.74 ± 4.15 | <0.001* |
| Stage of CE [18]/AE [10] | 0.154 | 0.001* | ||||
| CE1/I | 43 | 21 | 29 | 4 | ||
| CE2/II | 60 | 27 | 25 | 7 | ||
| CE3/IIIa | 14 | 6 | 9 | 11 | ||
| CE4/IIIb | 8 | 4 | 18 | 3 | ||
| CE5/IV | 40 | 9 | 30 | 26 | ||
| Hepatitis B | 96 | 28 | 49 | 27 | 0.047* | |
| Gallbladder diseases | 51 | 30 | 34 | 35 | 0.092 | |
| Echinococcosis disseminated [21] | 14 | 9 | 11 | 17 | 0.125 | |
| Number of comorbidities | 0.106 | 0.255 | ||||
| 0 | 39 | 8 | 22 | 6 | ||
| 1–2 | 77 | 36 | 56 | 25 | ||
| 3–5 | 38 | 16 | 24 | 18 | ||
| > 5 | 11 | 7 | 10 | 2 | ||
Abbreviations: BMI, Body Mass Index; ALB, albumin; HGB, hemoglobin; LYMPH, Lymphocyte.
*
Values expressing statistical significance (p ≤ 0.05).